Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Levodopa only product in oral dose form |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa and levodopa only product in enteral dose form |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, oral tablett |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, oral tablett |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 250 milligram, oral tablett |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 250 milligram, oral tablett |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing benserazide and levodopa in oral dose form (medicinal product form) |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Benserazide and levodopa only product in oral dose form |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 10 milligram och levodopa 100 milligram, oral tablett |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 10 milligram och levodopa 100 milligram, oral tablett |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Benserazide 25 mg and levodopa 100 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Benserazide 25 mg and levodopa 100 mg oral capsule |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa- and levodopa-containing product in oromucosal dose form |
Has active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 12,5 milligram och levodopa 50 milligram, oral tablett |
Has basis of strength substance (attribute) |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
karbidopa (som karbidopamonohydrat) 12,5 milligram och levodopa 50 milligram, oral tablett |
Has precise active ingredient |
False |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levodopa (substance) |
Inferred relationship |
Some |
2 |